ELOVL2 and posterior cortical atrophy: Collectively, these findings demonstrate that ELOVL2 maybe upregulates AR protein expression by inhibiting the ubiquitin-proteasome pathway, thereby enhancing AR signaling and contributing to enzalutamide resistance in PCa cells.